Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
Clinical trial NCT00159770 · COMPLETED
Trial details
- NCT number
- NCT00159770
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.